Armor Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,790
Closed -$224K 163
2021
Q3
$224K Sell
1,790
-100
-5% -$12.9K 0.14% 112
2021
Q2
$235K Hold
1,890
0.14% 110
2021
Q1
$223K Hold
1,890
0.14% 107
2020
Q4
$221K Buy
+1,890
New +$208K 0.16% 102
2020
Q1
Sell
-2,040
Closed -$231K 144
2019
Q4
$231K Sell
2,040
-100
-5% -$11K 0.18% 98
2019
Q3
$232K Hold
2,140
0.19% 89
2019
Q2
$208K Sell
2,140
-100
-4% -$9.13K 0.18% 97
2019
Q1
$204K Hold
2,240
0.18% 97
2018
Q4
$204K Hold
2,240
0.21% 88
2018
Q3
$220K Sell
2,240
-200
-8% -$18.5K 0.2% 95
2018
Q2
$209K Sell
2,440
-100
-4% -$8.35K 0.19% 96
2018
Q1
$204K Buy
+2,540
New +$210K 0.19% 98

Other funds holding MDT

Armor Investment Advisors's MDT Position: Q4 2021 in Review

Armor Investment Advisors sold out of Medtronic (MDT) in Q4 2021, closing a stake of 1,790 shares — an estimated $224K sold.

Armor Investment Advisors first reported a position in MDT in Q1 2018 and held it in 12 quarters. The position peaked at $235K in Q2 2021. 2,060 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Armor Investment Advisors reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Armor Investment Advisors sold 1,790 Medtronic shares in Q4 2021, an estimated $224K.
  • Armor Investment Advisors first reported a position in Medtronic in Q1 2018 and held it in 12 quarters.
  • Armor Investment Advisors's Medtronic position peaked at $235K in Q2 2021.
  • 2,060 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Armor Investment Advisors's 13F filing for Q4 2021, filed 7 Feb 2022.